Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B.
暂无分享,去创建一个
E. Antman | E. Braunwald | C. Cannon | E. Braunwald | J. Winkelman | C. Gibson | D. Wybenga | M. Tanasijevic | G. A. Fischer | C. Grudzien | C. Gibson | Christopher P. Cannon | James W Winkelman
[1] R. Giugliano,et al. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators. , 1998, Circulation.
[2] E. Antman,et al. Myoglobin, creatine kinase MB, and cardiac troponin-I to assess reperfusion after thrombolysis for acute myocardial infarction: results from TIMI 10A. , 1997, American heart journal.
[3] D Wybenga,et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. , 1996, The New England journal of medicine.
[4] T. Henry,et al. Early monitoring of serum cardiac troponin I for assessment of coronary reperfusion following thrombolytic therapy. , 1996, American journal of clinical pathology.
[5] P. Steg,et al. A study of biochemical markers of reperfusion early after thrombolysis for acute myocardial infarction. The PERM Study Group. Prospective Evaluation of Reperfusion Markers. , 1995, Circulation.
[6] T. Henry,et al. Cardiac troponin, CK-MB and myoglobin for the early detection of acute myocardial infarction and monitoring of reperfusion following thrombolytic therapy. , 1995, Clinica chimica acta; international journal of clinical chemistry.
[7] J. Mccabe,et al. Is myoglobin useful in the diagnosis of acute myocardial infarction in the emergency department setting? , 1995, American journal of clinical pathology.
[8] E. Topol,et al. Creatine kinase MM and MB isoforms in patients receiving thrombolytic therapy and acute angiography. TAMI Study Group. , 1995, Clinical chemistry.
[9] K. Daly,et al. Comparison of five cardiac markers in the detection of reperfusion after thrombolysis in acute myocardial infarction. , 1995, British heart journal.
[10] C. Cannon,et al. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial. , 1994, Journal of the American College of Cardiology.
[11] J. Ishii,et al. Early detection of successful coronary reperfusion based on serum myoglobin concentration: comparison with serum creatine kinase isoenzyme MB activity. , 1994, American heart journal.
[12] A. Jaffe,et al. Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I. , 1994, Clinical chemistry.
[13] M. Miyata,et al. Rapid diagnosis of coronary reperfusion by measurement of myoglobin level every 15 min in acute myocardial infarction. , 1994, Journal of the American College of Cardiology.
[14] C. Bode,et al. Assessment of reperfusion of the infarct zone after acute myocardial infarction by serial cardiac troponin T measurements in serum. , 1994, British heart journal.
[15] E. Braunwald. The open-artery theory is alive and well--again. , 1993, The New England journal of medicine.
[16] Gusto Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. , 1993, The New England journal of medicine.
[17] R. Califf,et al. Noninvasive detection of reperfusion after thrombolysis based on serum creatine kinase MB changes and clinical variables. TAMI 7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction. , 1993, American heart journal.
[18] Jack H. Ladenson,et al. Cardiac Troponin I A Marker With High Specificity for Cardiac Injury , 1993, Circulation.
[19] S. Hohnloser,et al. Analysis of Creatine Kinase, CK‐MB, Myoglobin, and Troponin T Time‐Activit Curves for Early Assessment of Coronary Artery Reperfusion After Intravenous Thrombolysis , 1993, Circulation.
[20] Frans Van de Werf,et al. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. , 1993, The New England journal of medicine.
[21] J. Ladenson,et al. Development of monoclonal antibodies for an assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarction. , 1992, Clinical chemistry.
[22] J. Ladenson,et al. Development and application of monoclonal antibodies to human cardiac myoglobin in a rapid fluorescence immunoassay. , 1991, Clinical chemistry.
[23] S. Hohnloser,et al. Assessment of coronary artery patency after thrombolytic therapy: accurate prediction utilizing the combined analysis of three noninvasive markers. , 1991, Journal of the American College of Cardiology.
[24] A. Remppis,et al. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. , 1991, The American journal of cardiology.
[25] T. Takala,et al. Serum carbonic anhydrase III and myoglobin concentrations in acute myocardial infarction. , 1990, Clinical chemistry.
[26] J. Chapelle,et al. Automated quantification of creatine kinase MB isoenzyme in serum by radial partition immunoassay, with use of the Stratus analyzer. , 1990, Clinical chemistry.
[27] E. Braunwald,et al. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded? , 1989, Circulation.
[28] F. Klocke,et al. Early noninvasive detection of successful reperfusion in patients with acute myocardial infarction. , 1988, Circulation.
[29] Sarah Parish,et al. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.
[30] B. Lewis,et al. Usefulness of a rapid initial increase in plasma creatine kinase activity as a marker of reperfusion during thrombolytic therapy for acute myocardial infarction. , 1988, The American journal of cardiology.
[31] H. Katus,et al. Non-invasive assessment of infarct reperfusion: the predictive power of the time to peak value of myoglobin, CKMB, and CK in serum. , 1988, European Heart Journal.
[32] R. Califf,et al. Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis. , 1988, Annals of internal medicine.
[33] H. Gold,et al. Detection of coronary artery reperfusion with creatine kinase-MB determinations during thrombolytic therapy: correlation with acute angiography. , 1988, Journal of the American College of Cardiology.
[34] R. Roberts,et al. Creatine kinase isoform analysis in the detection and assessment of thrombolysis in man. , 1987, Circulation.
[35] E. Topol,et al. Prediction of infarct coronary artery recanalization after intravenous thrombolytic therapy. , 1987, The American journal of cardiology.
[36] Y. Ohtsuki,et al. ISOLATION OF HTLV-I FROM CEREBROSPINAL FLUID OF A PATIENT WITH MYELOPATHY , 1986, The Lancet.
[37] M. Krucoff,et al. Noninvasive detection of coronary artery patency using continuous ST-segment monitoring. , 1986, The American journal of cardiology.
[38] J. Ladenson,et al. Direct measurement of creatine kinase-MB activity in serum after extraction with a monoclonal antibody specific to the MB isoenzyme. , 1986, Clinical chemistry.
[39] Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico.. EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION , 1986, The Lancet.
[40] A. R. Zaki Masud,et al. Patterns of myoglobin release after reperfusion of injured myocardium. , 1985, Circulation.
[41] H. S. Mueller,et al. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.
[42] J. Hanley,et al. The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.
[43] E. Veys,et al. HL-A AND INFECTIVE SACROILEITIS , 1974 .